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Abstract: Adverse effects of wound healing, such as exces-
sive scar tissue formation, wound contraction, or nonhealing
wounds represent a major clinical issue in today’s health-
care. Transforming growth factor (TGF)-3 has speciﬁcally
been implicated in wound healing. Our hypothesis was that
local administration of TGF-3 to excisional dermal wounds
would diminish wound contraction and scar formation. Mi-
crotextured wound covers, containing different concentra-
tions of TGF-3, were placed onto full-thickness excisional
skin wounds in guinea pigs. Tattooed reference marks were
used to quantify wound contraction. Sixty-four male guinea
pigs in four study groups (5 ng TGF-3, 50 ng TGF-3, no
growth factor, sham wound) were followed for up to 6
weeks. We analyzed 19 different parameters of wound heal-
ing. Results showed that, in some instances, the 50-ng
TGF-3 group gave less contraction, whereas the 5-ng
TGF-3 group gave more contraction. These differences con-
ﬁrm that TGF-3 has an optimum working concentration,
and suggest this concentration to be closer to 50 ng than to
5 ng TGF-3. However, only very few signiﬁcant differences
occurred, and thus we conclude that the clinical relevance of
our ﬁndings is negligible. Earlier studies, reporting clinically
improved wound healing by TGF-3, could therefore not be
conﬁrmed by this study. © 2004 Wiley Periodicals, Inc.
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INTRODUCTION
Adverse effects of wound healing, such as excessive
scar tissue formation, wound contraction, or nonheal-
ing wounds represent a major clinical issue in today’s
healthcare. Therefore, research that leads to the devel-
opment of methods that can improve wound healing
and its deleterious effects is challenging as well as
relevant. Biomaterials may be used to modify wound
healing, either as matrices to support and promote
tissue organization, or as barriers to limit scar tissue
formation. Another utilization for biomaterials is as a
carrier for bioactive substances, such as cytokines,
growth factors, or living cells.1–4 Examples of carriers
that have been used in the past include polymers,2
collagen,1 and liposomes.3 Previously, we studied cel-
lular and tissue response to polymeric implants con-
taining a standardized pattern of shallow surface mi-
crogrooves.2 These microtextured polymers can be
used as carriers for cytokines or growth factors.
Transforming growth factor (TGF)-3 has speciﬁ-
cally been implicated in wound healing. Exogenous
injection of TGF-3 into cutaneous, incisional wounds
in rats resulted in a marked improvement of the ar-
chitecture of the neodermis and a reduction in scar-
ring. The treatment of wounds with TGF-3 also in-
duced a lower monocyte and macrophage content,
increased vascularization, and gave rise to a lower
ﬁbronectin, collagen I, and collagen III deposition in
the earlier stages of healing.5 TGF-3 has been shown
to have a role in scarring, ﬁbrosis,6,7 and induction of
apoptosis,8 and has been investigated in different clin-
ical areas.6,9,10
Several animal models have been used with success,
to study the effects of growth factors on dermal
wound healing. These models include mice,1,11–15
rats,5,14,16–20 rabbits,12,21–25 guinea pigs,3,11,15,17,26–35
and pigs.11,30,36–40 When choosing a laboratory animal
for a dermal wound healing study, one has to consider
certain aspects, which are associated with a particular
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animal. Guinea pigs31 and pigs11,36,37 were docu-
mented to have an epidermis and dermis that have
more similarities with human skin than other animals.
A variety of wound types have been used in dermal
wound-healing research. These can be divided into
incisional wounds, which are closed after wound-
ing,14,16,18,25 or excisional wounds.1,3,5,11–15,17–24,26–
29,31–40 The method of creation of the wound can also
vary. Wounds were created surgically,1,11,14,18,19,21,25–
28,30,38–40 with a punch biopsy,3,11–13,15,20,22,24,29,35,37 or
thermally; these were either contact burns,14,23,33,34,36
scald burns,17,31,36 or radiation-induced burns.12 The
size of the wounds also varied, from 3–8
mm3,11,12,15,20,22,24,29,35,37 to 5–6 cm.11,14,16,18,25–27 If the
closure of dermal wounds in rodents is to a large
extent governed by rapid contraction,41 caution has to
be taken with respect to the size of the dermal defect.
If the object of the study is to evaluate epithelial cov-
erage, then the wound has to be large enough to
prevent closure by contraction alone, before epithelial
coverage is substantial.
We hypothesized that diminished wound contrac-
tion and scar formation in full-thickness excisional
dermal wounds could be attained with a microtex-
tured material loaded with TGF-3. To objectively
evaluate this, we made a full-thickness surgical
wound in the skin of adult guinea pigs. Subsequently,
we quantiﬁed wound contraction, epithelial regener-
ation, scar tissue formation, and histological charac-
teristics of the healing wound.
MATERIALS AND METHODS
Study design
In this study, a silicone membrane was used to cover an
experimentally induced full-thickness dermal wound in
adult guinea pigs. Based on previous studies,42–44 this mem-
brane was equipped with a microtexture. A set number of
these membranes was loaded with one of two concentra-
tions of TGF-3, whereas others were not loaded with the
growth factor. An earlier study showed that TGF-3 is re-
leased from such membranes, with a burst release in the ﬁrst
24 h, and complete release in 7 days.44 To avoid an inﬂuence
on wound closure, at 1 week after application, the silicone
membranes were removed. Then, the lesions were photo-
graphed, and the bandages were applied again. At 3 weeks
after application, the lesions were again photographed. In
one group, the animals were then sacriﬁced, and the wound
tissue was excised and histologically assessed. A second
group of animals was followed for an additional 3 weeks,
until 6 weeks after application (Table I).
Silicone substrate production
Using photolithographic techniques, microgrooved pat-
terns with a groove depth of 1.0 m and a ridge and groove
width of 10.0 m were made in molds of silicone (C2V;
Enschede, the Netherlands). To obtain a single-sided micro-
texture, a medical-grade silicone rubber (polydimethylsilox-
ane, NuSil MED-4211; NuSil Technology, Carpinteria, CA)
was cast on a mold. After polymerization, the silicone rub-
ber sheet was removed from the mold. From several sheets,
coin-shaped substrates of 1-mm thickness and 20-mm diam-
eter were cut. To prevent tissue reaction to leaching of
monomer or other components, the substrates were washed
in 10% liquinox solution (Alconox, New York, NY) for 3 min,
cleaned ultrasonically in 1% liquinox for 5 min, and rinsed
thoroughly three times in reverse osmosis water (Millipore
Corp., Bedford, MA). Then they were washed in 70% and
100% alcohol, and dried in air. Finally, TGF-3 (human
recombinant; Sigma-Aldrich Co., St. Louis, MO) was loaded
onto the surface and subsequently freeze-dried overnight.
Based on a previous study, we used either 5 or 50 ng of
TGF-3 per membrane.5
Guinea pigs
A total of 64 speciﬁed pathogen-free male albino Hartley-
derived guinea pigs were used, weighing approximately
700 g. The animals were kept in the laboratory according to
national guidelines, and received chow and water ad libitum.
Each guinea pig had one wound on its right ﬂank, contain-
ing one of the following: a membrane coated with 5 ng of
TGF-3, with 50 ng of TGF-3, a membrane without growth
factor (controls), or a sham wound (without a membrane).
The study protocol was approved by our Universities’ An-
imal Ethics Committee and all experiments were performed
according to the Experiments on Animals Act and under
appropriate licenses.
Application procedure
Surgery was performed under general inhalation anesthe-
sia of O2, N2O, and isoﬂurane. The right ﬂank of the animal
was shaved. Before incision, the skin was scrubbed with
TABLE I
The Study Set-Upa Used
Period Category n
3 weeks Sham 8
Control 8
5 ng TGF-3 8
50 ng TGF-3 8
6 weeks Sham 8
Control 8
5 ng TGF-3 8
50 ng TGF-3 8
Total 64
aSixty-four guinea pigs divided over two times four cate-
gories: sham, control, loaded with 5 ng TGF-3, and loaded
with 50 ng TGF-3. Half were followed for 3 weeks, the
other half for 6 weeks.
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iodine. Standardized orientation points to measure wound
contraction were created with tattooing ink, using ﬁxed
holes in a premade steel mold (Fig. 1). Reproducible circular
full-thickness dermal wounds of identical size and depth
were created on the right ﬂank of the guinea pigs, using
aseptical techniques. Wounds were made with the use of a
20-mm  circular hole in the mold. A full-thickness wound
was created by incising the tissue along the perimeter of the
hole extending to the panniculus carnosus, and excising the
remaining tissue within these boundaries. The silicone sub-
strates were sutured into the wound with their smooth sides
facing the dressing and subsequently covered by semiper-
meable polyurethane dressing (Tegaderm; 3M Co., Minne-
apolis, MN), thereby creating a moist wound environment.
One layer of dry sterile ﬁne-mesh gauze (Tendra Mesoft 5 
5 cm; Mo¨lnlycke, Go¨teborg, Sweden) was applied onto the
Tegaderm and the dressings were secured in place with two
circular layers of surgical tape (Elastoplast-E 6 cm; Beiers-
dorf, Spain). After 1 week, membranes were removed and
standardized digital photographs were made to quantify
wound contraction and re-epithelialization. Afterward, the
bandages were reapplied. After 3 and (where applicable) 6
weeks, digital photographs were taken again. Animals were
sacriﬁced by intraperitoneal injection of a lethal dose of
pentobarbital, after which wound tissue was retrieved for
histological analysis.
Morphometrical evaluation of the wounds
The method of evaluation was adapted from previous
publications.21,33 Standardized digital wound photographs
were taken on days 7, 21, and (where applicable) day 42,
using a Minolta DiMAGE 7 digital camera (Minolta Co. Ltd.,
Osaka, Japan) on macro setting. Distances were calibrated
with a ruler on each photograph, using Leica Qwin software
(Leica Microsystems Imaging Solutions Ltd., UK). Per pho-
tograph, 19 parameters were measured (Fig. 1): sides S1–S4
(distance between tattoo reference marks); radii R1–R4 (dis-
tance between tattoo marks and center of wound); diagonals
D1–D2 (distance between diagonally opposing tattoo
marks); wound surface area (WSA); wound perimeter (WP);
wound roundness; reference surface area (RSA, area be-
tween tattoo marks); reference area perimeter (RAP, total of
S1  S2  S3  S4); and angles A1–A4 (angles between
tattoo marks).
Histological evaluation techniques
After retrieval, the excised wound tissue was ﬁxed in 4%
buffered formalin for 4 h, dehydrated in a series of ethanol,
and embedded in parafﬁn. Thereafter, 5-m sections were cut
using a Leica RM 2165 Microtome equipped with a D knife
(Rijswijk, the Netherlands). Every twenty-ﬁfth section was
collected and stained with hematoxylin and eosin (Merck,
Darmstadt, Germany).
-smooth muscle actin (SMA) staining
The presence and number of myoﬁbroblasts were deter-
mined by staining for -SMA. Deparafﬁnated sections were
treated with 3% H2O2 in phosphate-buffered saline (PBS) for
30 min to block endogenous peroxidase and rinsed in PBS at
room temperature. Then, the sections were preincubated
with 20% normal donkey serum in PBS (Biomeda, Foster
City, CA). After preincubation, the sections were incubated
with monoclonal immunoglobulin G2a mouse anti–-SMA
(Sigma Chemical Co., St. Louis, MO) 1:1200 overnight at 4°C.
After washing with PBS, the sections were incubated with
biotinylated donkey anti-mouse secondary antibody (Jack-
son Laboratories, West Grove, PA) 1:500 for 60 min. The
sections were then rinsed three times in PBS. Staining was
performed with a biotin-streptavidin detection system for 45
min (Vectra elite kit; Vector Laboratories, Burlingame, CA).
Positive controls (blood vessel walls) and negative controls
(PBSA 1%) were included. Slides were reviewed with 100
and 400magniﬁcation for the presence of positive-staining
myoﬁbroblasts. Positive cells in blood vessel walls were not
taken into consideration. Sections were separately reviewed
for positive-staining cells directly below the epithelial lining
and deeper in the lower two-thirds of the biopsy. Staining
was evaluated quantitatively on a scale of 0–5, estimating
the number of cells from about 10 (1) to more than 100 (5) in
total. Three sections per wound, each 25 m apart, were
scored.
Histomorphometry
Computer-based image analysis of wound area and re-
epithelialization was performed using histological images,
Figure 1. The premade aluminum mold with 20-mm 
hole and four tattoo reference marks. In the photograph, the
19 measurement parameters are indicated: sides (S1–S4),
radii (R1–R4), diagonals (D1–D2), angles between tattoo
marks (A1–A4), WSA, WP, and RSA. Not shown: wound
roundness, and RAP ( S1  S2  S3  S4). On the left, the
ruler used for calibration is seen. [Color ﬁgure can be
viewed in the online issue, which is available at www.
interscience.wiley.com.]
404 VOOIJS ET AL.
projected with a total magniﬁcation of 16 from a DMRBE
Leica microscope on a color monitor, with a Leica camera
(DC 200) attached to the microscope. Per wound, three his-
tology sections 125 m apart, were selected for evaluation.
In these sections, epithelial coverage, thickness, and width of
the neo-epithelial layer and size of wound opening (distance
between epithelial margins) were measured at predeter-
mined locations in the wound. Measurements were made in
ﬁve different areas (Fig. 2): 1. re-epithelialized area, 2. left
edge of neo-epithelium, 3. center of neo-epithelium, 4. right
edge of neo-epithelium, and 5. wound opening (where ap-
plicable).
Statistical analysis
The averages and standard deviations of triplicate data
from the quantitative measurements were calculated. Then,
the data were compared with a one-way analysis of variance
and a Tukey post hoc test, using InStat software (version 3.05;
GraphPad Inc., San Diego, CA). A p value 0.05 was con-
sidered to be signiﬁcant.
RESULTS
Surgery
No wound infections occurred throughout the ex-
periment. There were no signiﬁcant differences in
weight at the time of operation or photography (day 0,
7, 21, or 42) among the groups. In total, six guinea
pigs, all in different groups, died before the end of the
experiment: two of aspiration pneumonia, three dur-
ing anesthesia, and one of an unknown cause. At day
7, none of the wounds were closed. At day 21, most
wounds were clinically closed. Some wound elonga-
tion was seen, but no marked wound contraction was
visible. At day 42, all wounds were fully closed and
markedly elongated, always parallel to the body axis
of the guinea pig. Some wound contraction was noted,
perpendicular to the body axis.
Morphometry on wound photographs
Data from all study groups were shown to have
normal Gaussian distribution, calculated using the
method of Kolmogorov and Smirnov. Differences
among groups and operation categories were calcu-
lated on days 7, 21, and 42.
On day 7, signiﬁcant differences among study cat-
egories were measured for parameters S3, R4, WSA,
and WP (Fig. 1). For S3 [Fig. 3(A)], the distance mea-
sured for 5-ng–coated membranes was signiﬁcantly
shorter than for 50-ng–coated membranes (p  0.05).
For parameter R4 [Fig. 3(B)], the distance measured
for controls was signiﬁcantly shorter than for 50-ng–
coated membranes (p  0.05). For parameter WSA
[Fig. 3(C)], the distance measured for 5-ng–coated
membranes was signiﬁcantly shorter than for sham
wounds and 50-ng–coated membranes (p  0.05). For
parameter WP [Fig. 3(D)], the distance measured for
5-ng–coated membranes was signiﬁcantly shorter
than for sham wounds (p  0.01) and signiﬁcantly
shorter than for controls (p  0.05).
On day 21, no signiﬁcant differences were measured
for any parameter. On day 42, signiﬁcant differences
were measured for parameters R1 and R4. In R1 [Fig.
3(E)], the distance measured for 5-ng–coated mem-
branes was signiﬁcantly shorter than for controls (p 
0.01) and signiﬁcantly shorter than for sham wounds
and 50-ng–coated membranes (p  0.05). In R4 [Fig.
3(B)], again (same as on day 7) the distance measured
for controls was signiﬁcantly shorter than for 50-ng–
coated membranes (p  0.05).
Histology
Three weeks after surgery, in most sections, the
squamous epithelial lining was missing, with a result-
ing superﬁcial central defect (Figs. 4 and 5). The un-
derlying stroma was replaced by a core of granulation
tissue, varying in width and at times reaching into the
Figure 2. Histomorphometrical parameters shown on a hematoxylin and eosin–stained example (original magniﬁcation,
40) from the 3-week sham group. (A) Wound opening, (B) thickness neo-epithelium left side, (C) thickness neo-epithelium
right side, (D) thickness neo-epithelium center of wound (not shown—wound still open), and (E) re-epithelialized area
[distance between (B) and (C)]. [Color ﬁgure can be viewed in the online issue, which is available at www.interscience.
wiley.com.]
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basal section plane (Fig. 6). In the core of granulation
tissue, a slight, mostly diffuse leukocytic inﬁltrate
(lymphocytes and polymorphonuclear granulocytes)
was observed. Macroscopically, there were no differ-
ences recognizable in the histological aspect of the
sections among the four groups of 3-week specimens.
In all sections of the 6-week specimens, an intact ke-
ratinizing squamous epithelial lining was seen, which
Figure 3. Signiﬁcant differences among operation groups for ﬁve parameters on days 7, 21, and 42 (*p  0.05, **p  0.01).
On day 42, signiﬁcant differences were only seen for parameters R1 and R4. [Color ﬁgure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
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in some cases showed the start of rete peg formation.
The central core of granulation tissue seemed to be
narrowed in the superﬁcial layers of the sections,
which might be due to contraction of newly formed
connective tissue. This was seen most prominently in
the 5-ng–loaded samples (Fig. 7). In the deeper layers
of the sections, a generally rather broad core of young
organized granulation tissue (young connective tis-
sue) was present, which spread out under the pre-
existent keratinizing squamous epithelium. Micro-
scopically, the overall image in the 50-ng specimens
seemed more irregular than the histological image of
the other groups. In specimens with 5 ng TGF-3, the
central core of young connective tissue seemed small-
est.
-SMA staining
In the majority of biopsies, no or only few positive
cells were found in the most superﬁcial layers directly
below the epithelial lining. In very few of the biopsies,
positive cells, not related to blood vessels, were found
in the deeper layers (Fig. 8). When present in larger
numbers, positive-staining cells were mostly located
directly below and parallel to the lining epithelium.
No signiﬁcant differences among the study groups
were detected in frequency and distribution of posi-
tive cells (Fig. 9).
Histomorphometry
In 3-week specimens, microscopically the central
core of granulation tissue in superﬁcial layers of the
biopsy seemed smallest in 5-ng TGF-3–loaded spec-
imens. In all 6-week specimens, intact epithelial lining
was seen and no differences could be shown to exist
anymore. No signiﬁcant differences could be shown to
exist among study groups or among operation catego-
ries (Fig. 10).
DISCUSSION AND CONCLUSION
The ﬁnal aim of this study was to evaluate whether
microtextured silicone membranes loaded with
TGF-3 could reduce contraction and scar formation
when placed in a dermal wound in vivo. To objectively
Figure 4. Histological sample from the sham wound group after 3 weeks. Note the centrally located epithelial defect with
blood clotting (original magniﬁcation, 40). [Color ﬁgure can be viewed in the online issue, which is available at www.
interscience.wiley.com.]
Figure 5. Histological sample from the unloaded membranes (control) group after 3 weeks. Note the re-epithelialization
from the wound edges toward the center (original magniﬁcation, 40). [Color ﬁgure can be viewed in the online issue, which
is available at www.interscience.wiley.com.]
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evaluate this, we made full-thickness surgical wounds
in the skin of adult guinea pigs, and evaluated char-
acteristics of the healing wounds. Other studies
mostly measure WP and WSA, but not all studies use
tattoo reference marks for measurement of wound
contraction. In this study, we planned to measure all
relevant wound-healing parameters described in the
literature. These included WP, WSA, and radii (dis-
tances between tattoo marks and wound). Our careful
set-up was designed to measure any change in
wound-healing characteristics.
First, we quantiﬁed wound contraction by morpho-
metrical evaluation of digital wound photographs. On
day 7, signiﬁcant differences among study categories
were seen for some of our wound-healing parameters:
R1 and R4. However, on day 21, no signiﬁcant differ-
ences were seen in any parameter, and also on day 42,
little signiﬁcant differences were seen. Overall, the
50-ng TGF-3 group seemed to give less contraction
than other groups. In contrast, in several parameters,
the 5-ng TGF-3 group is shown to give even more
contraction than other groups. These differences con-
ﬁrm the fact that TGF-3 has an optimum working
concentration22,45 and suggest this optimum working
concentration to be closer to 50 ng than to 5 ng TGF-
3. The average WP decreased from day 7 to day 21,
and then increased again to day 42. This was probably
caused by contraction of the wound until week 3, and
then closure but also elongation of the wound, increas-
ing the WP again. This effect was strongest in the early
stages of wound healing, conﬁrming the time-depen-
dent working mechanism of TGF-.24,46 These results
only seem to conﬁrm a minor role for TGF-3 in the
early stages of wound healing.10 The clinical relevance
for the differences in these speciﬁc parameters at day
42 is very disputable. All operations were performed
on the same location on the right ﬂank of the guinea
pig. Some signiﬁcant differences were found in pa-
rameters in the posterior half of the wound area, none
in the anterior half. This difference in anterior–poste-
rior healing in rodent wounds was already previously
described.8
Resuming, from the clinical observations, we can
conclude that most of the parameters we measured
either did not show signiﬁcant differences among
study groups, or do not provide information relevant
to wound healing or wound contraction in this model.
In addition to the clinical observations, we histo-
Figure 6. Histological sample from the 5-ng–loaded membranes group after 3 weeks. (A) Centrally located defect (wound
opening), (B) central core of granulation tissue, (C) pre-existent connective tissue, and (D) pre-existent epithelial lining
(original magniﬁcation, 40). [Color ﬁgure can be viewed in the online issue, which is available at www.interscience.
wiley.com.]
Figure 7. Histological sample from the 5-ng–loaded membranes group after 6 weeks. (A) Intact keratinizing squamous
epithelial lining, (B) centrally narrowed core of granulation tissue, (C) pre-existent connective tissue, and (D) pre-existent
epithelial lining (original magniﬁcation, 40). [Color ﬁgure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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morphometrically analyzed sections of our healing
wounds. In the 3-week specimens, the central core of
granulation tissue in superﬁcial layers of the biopsy
seemed smallest in 5-ng TGF-3–loaded specimens.
This might be due to contraction of newly formed
connective tissue, and suggests more rapid wound
contraction in the 5-ng samples, especially in the early
stages of wound healing. This is concurrent with our
ﬁndings for that group in morphometry. In all 6-week
specimens, intact epithelial lining was seen and no
differences could be shown to exist among groups
anymore. Any differences visible at 3 weeks had dis-
appeared in the 6-week samples. In the -SMA–
stained slides, this possible difference in contraction
early in the wound-healing process could not be con-
ﬁrmed. It is possible that differences present before,
had already disappeared at 3 weeks, as suggested
earlier.47 Although there seemed to be more positive-
staining cells in the 3-week samples, there was no
statistically signiﬁcant difference demonstrable.
These results could again only conﬁrm a minor
inﬂuence of TGF-3 in the early stages of healing.
They suggest that TGF-3 has some inﬂuence on
Figure 8. Immunohistochemical staining for -SMA, sam-
ple from the 50-ng–loaded membranes group after 6 weeks.
(A) -SMA positive-stained myoﬁbroblasts, (B) capillary
wall, and (C) granulation tissue (original magniﬁcation,
100). [Color ﬁgure can be viewed in the online issue, which
is available at www.interscience.wiley.com.]
Figure 9. No signiﬁcant differences in -SMA positive-
staining cells. [Color ﬁgure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
Figure 10. Histomorphometrical measurements at 6 weeks
on the epithelial layer. (A) Average thickness of neo-epithe-
lial layer, (B) length of neo-epithelium, and (C) length of
wound opening (for parameters see Fig. 2). No signiﬁcant
differences were found among operation categories at 3
weeks, or at 6 weeks (original magniﬁcation, 40). [Color
ﬁgure can be viewed in the online issue, which is available
at www.interscience.wiley.com.]
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wound healing, but little inﬂuence on ﬁnal wound
contraction in this model.
An earlier study by Shah et al.5 showed a positive
inﬂuence of TGF-3 on wound healing in a rat inci-
sional wound model. This inﬂuence could not be con-
ﬁrmed in our study. This could be caused by differ-
ences in the study set-up. We used guinea pigs
because of the great similarity with human skin. How-
ever, still there are differences with earlier studies in
wound type, application method, the use of a carrier,48
etc. Still, the applicability of TGF-3 in clinical wound
healing might be smaller at this point in time than
previously suspected. To date, the earlier promising
results using TGF-3 in incisional dermal wounds
have not been conﬁrmed to be clinically relevant.
In conclusion, we investigated the inﬂuence of dif-
ferent concentrations of TGF-3 on wound healing
and skin contraction in an excisional wound model in
the guinea pig. No clinically relevant signiﬁcant dif-
ferences were shown to exist among study groups or
among operation categories in this model. Thus, our
hypothesis that enhanced wound healing in full-thick-
ness excisional dermal wounds would be attained un-
der the inﬂuence of a microtextured material loaded
with TGF-3, could not be conﬁrmed.
The authors thank W. W. H. P. A. Meijer, M. P. A. C.
Helmich, R. E. M. van Rheden, and J. P. C. M van der
Waerden for technical assistance, and G. P. Vooijs for assis-
tance in histological evaluation.
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